Standards, options and recommendations for the management of stage I and II non small cell lung carcinoma treated by radiotherapy alone;Standards, options et recommandations pour la prise en charge des patients atteints d'un cancer bronchique primitif de stade I ou II traités par irradiation exclusive

Cancer/Radiotherapie

Volumn 5, Issue 4, 2001, Pages 452-463

  Touboul, E ^a,b   Lagrange, J L ^a,b   Theobald, S ^a,b   Astoul, P ^a,b   Baldeyrou, P ^a,b   Bardet, E ^a,b   Bazelly, B ^a,b   Brechot J ^a,b   Breton, J L ^a,b   Douillard, J Y ^a,b   Grivaux, M ^a,b   Jacoulet, P ^a,b   Khalil, A ^a,b   Le Chevalier, T ^a,b   Lemarie, E ^a,b   Martinet, Y ^a,b   Massard, G ^a,b   Milleron, B ^a,b   Moro Sibilot, D ^a,b   Paesmans, M ^a,b   Pujol, J L ^a,b   Quoix, A E ^a,b   Ranfaing, E ^a,b   Riviere A ^a,b   Sancho Garnier, H ^a,b   Souquet, P J ^a,b   Spaeth, D ^a,b   Stoebner Delbarre, A ^b   Thiberville, L ^a,b   Vaylet, F ^a,b   Vergnon, J M ^a,b   Westeel, V ^a,b   Depierre, A ^a,b   more..

^a FNCLCC   (France)

^b NONE

Author keywords

Adult; Neoplasm staging; Non small cell lung carcinoma; Radiotherapy; Recommendations for clinical practice

Indexed keywords

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; LUNG NON SMALL CELL CANCER; MEDIASTINUM LYMPH NODE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVIEW; TUMOR VOLUME;

EID: 0034896881     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(01)00116-0     Document Type: Review

References (41)

1. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer
2. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11
3. Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication
4. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies
5. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?
6. Méthodologie de développement des Standards, Options et Recommandations diagnostiques et thérapeutiques en cancérologie
7. Randomized trial of lobectomy versus limited resection for T1 NO non-small cell lung cancer
8. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung
9. Radical radiotherapy for early nonsmall cell lung cancer
10. Development of multifield three-dimensional conformal radiotherapy of lung cancer using a total lung dose/volume histogram
11. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer
12. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence
13. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis
14. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer
15. Radiation therapy alone for stage I non-small cell lung cancer
16. The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma
17. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?
18. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone
19. Physical and biological predictors of changes in whole-lung function following thoracic irradiation
20. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis
21. Incidence of local recurrence and second primary tumors in resected stage I lung cancer
22. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients
23. The treatment of carcinoma of the bronchus: A clinical trial to compare surgery and supervoltage radiotherapy
24. A new international staging system for lung cancer
25. Prognosis and survival in resected lung carcinoma based on the new international staging system
26. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer
27. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis
28. Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease
29. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group
30. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: Report by the Radiation Therapy Oncology Group
31. Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease)
32. Treatment of roentogenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low dose rate brachytherapy
33. The assessment of tumor response to irradiation of lung cancer: Continuous versus split-course regimes
34. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer
35. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience
36. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer
37. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer
38. Remote after loading brachytherapy for the local control of endobronchial carcinoma
39. Curative radiotherapy in non-small cell carcinoma of the lung
40. Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction
41. Curative radiotherapy of early operable non-small cell lung cancer